CHEK2 and prostate carcinoma: CHEK2 mutations were identified in three patients; mutations in this gene are associated with increased risk in breast, colon, and prostate cancer (Hale et al. 2014; Leedom et al. 2016; Shaag et al. 2005; Wang et al. 2015).